1128 related articles for article (PubMed ID: 27713629)
1. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD.
Chen FJ; Huang XY; Liu YL; Lin GP; Xie CM
Int J Chron Obstruct Pulmon Dis; 2016; 11():2385-2390. PubMed ID: 27713629
[TBL] [Abstract][Full Text] [Related]
2. [The value of fractionated exhaled nitric oxide in the diagnosis of asthma-chronic obstructive pulmonary disease overlap syndrome].
Deng DD; Zhou AY; Shuang QC; Chen P
Zhonghua Jie He He Hu Xi Za Zhi; 2017 Feb; 40(2):98-101. PubMed ID: 28209039
[No Abstract] [Full Text] [Related]
3. Validity of fractional exhaled nitric oxide and small airway function indices in diagnosis of cough-variant asthma.
Feng-Jia C; Xin-Yan H; Geng-Peng L; Yang-Li L; Can-Mao X
J Asthma; 2018 Jul; 55(7):750-755. PubMed ID: 28846444
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value and influencing factors of fractional exhaled nitric oxide in suspected asthma patients.
Wang Y; Li L; Han R; Lei W; Li Z; Li K; Kang J; Chen H; He Y
Int J Clin Exp Pathol; 2015; 8(5):5570-6. PubMed ID: 26191266
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of fractional exhaled nitric oxide for asthma-chronic obstructive pulmonary disease overlap syndrome.
Guo Y; Hong C; Liu Y; Chen H; Huang X; Hong M
Medicine (Baltimore); 2018 Jun; 97(23):e10857. PubMed ID: 29879019
[TBL] [Abstract][Full Text] [Related]
6. Biomarker-based detection of asthma-COPD overlap syndrome in COPD populations.
Tamada T; Sugiura H; Takahashi T; Matsunaga K; Kimura K; Katsumata U; Takekoshi D; Kikuchi T; Ohta K; Ichinose M
Int J Chron Obstruct Pulmon Dis; 2015; 10():2169-76. PubMed ID: 26491283
[TBL] [Abstract][Full Text] [Related]
7. Characterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot study.
Donohue JF; Herje N; Crater G; Rickard K
Int J Chron Obstruct Pulmon Dis; 2014; 9():745-51. PubMed ID: 25053884
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap.
Takayama Y; Ohnishi H; Ogasawara F; Oyama K; Kubota T; Yokoyama A
Int J Chron Obstruct Pulmon Dis; 2018; 13():2525-2532. PubMed ID: 30174422
[TBL] [Abstract][Full Text] [Related]
9. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added].
Schneider A; Tilemann L; Schermer T; Gindner L; Laux G; Szecsenyi J; Meyer FJ
Respir Res; 2009 Mar; 10(1):15. PubMed ID: 19254389
[TBL] [Abstract][Full Text] [Related]
10. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
11. Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?
Karampitsakos T; Gourgoulianis KI
Med Hypotheses; 2016 Jun; 91():20-23. PubMed ID: 27142135
[TBL] [Abstract][Full Text] [Related]
12. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
[TBL] [Abstract][Full Text] [Related]
13. FENO measurement and sputum analysis for diagnosing asthma in clinical practice.
Schneider A; Schwarzbach J; Faderl B; Welker L; Karsch-Völk M; Jörres RA
Respir Med; 2013 Feb; 107(2):209-16. PubMed ID: 23107283
[TBL] [Abstract][Full Text] [Related]
14. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
Li M; Yang T; He R; Li A; Dang W; Liu X; Chen M
Int J Chron Obstruct Pulmon Dis; 2020; 15():3025-3037. PubMed ID: 33244228
[TBL] [Abstract][Full Text] [Related]
15. Albuterol inhalation increases FeNO level in steroid-naive asthmatics but not COPD patients with reversibility.
Zhao H; Li R; Lv Y; Dong H; Yao L; Wu Y; Xiao G; Cai S
Clin Respir J; 2017 May; 11(3):328-336. PubMed ID: 26077165
[TBL] [Abstract][Full Text] [Related]
16. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
[TBL] [Abstract][Full Text] [Related]
17. [Values of fractional exhaled nitric oxide in the diagnosis of chronic cough].
Zhang YM; Lin JT; Su N; Chen X; Liu GL; Yu HX; Nong Y; Zhang XY; Yang M; He J; Li YM
Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1254-8. PubMed ID: 21756797
[TBL] [Abstract][Full Text] [Related]
18. Clinical utility of ultrahigh fractional exhaled nitric oxide in predicting bronchial hyperresponsiveness in patients with suspected asthma.
Liu J; Xu R; Zhan C; Luo W; Lai K; Zhong N; Chen W; Chen R
Postgrad Med J; 2019 Oct; 95(1128):541-546. PubMed ID: 31296792
[TBL] [Abstract][Full Text] [Related]
19. Converting F
Lassmann-Klee PG; Lehtimäki L; Lindholm T; Malmberg LP; Sovijärvi ARA; Piirilä PL
Clin Physiol Funct Imaging; 2019 Sep; 39(5):315-321. PubMed ID: 31058423
[TBL] [Abstract][Full Text] [Related]
20. Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007-2012.
Goto T; Camargo CA; Hasegawa K
Int J Chron Obstruct Pulmon Dis; 2016; 11():2149-2155. PubMed ID: 27660432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
